Biotech Values

[mcbio]

Absent a complete meltdown in EU, MNTA seems a relatively safe and high yielding place to invest.

To me, it's kind of funny you hear all the talk about potential global recession and potential cutback in reimbursements, etc. Well, wouldn't you think a company that is in the business of lowering healthcare costs would be a beneficiary of these difficult times? Of course, MNTA just gets lumped in with everyone else that is being hit hard these days. But, I think, if anything, fundamentals have improved in these difficult times. I don't see a complete meltdown in the EU having a material effect on U.S. mL sales.